Effect of the tyrosine kinase inhibitor lapatinib on CUB-domain containing protein (CDCP1)-mediated breast cancer cell survival and migration
2011 ◽
Vol 414
(1)
◽
pp. 226-232
◽
Keyword(s):
Keyword(s):
Keyword(s):
2017 ◽
Vol 40
(10)
◽
pp. 1747-1753
◽
Keyword(s):
Keyword(s):
2010 ◽
Vol 28
(15_suppl)
◽
pp. e13657-e13657
Keyword(s):